DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vaccitech
Vaccitech
Chadox1 Ncov-19 Vaccine Prevents SARS-Cov-2 Pneumonia in Rhesus Macaques
Intrinsic Features in Spinouts UK
'Astrazeneca' Covid-19 Vaccine
Corporate Presentation
Title in Here, Arial 14 Bold, Caps
Vaccitech FLU009 Protocol V1.0 14December2018
Relatório Técnico – Monitoramento De Vacinas Em Desenvolvimento Contra Sars-Cov-2
VACCITECH PLC (Exact Name of Registrant As Specified in Its Charter)
Who Funded the Research Behind the Oxford-Astrazeneca COVID-19 Vaccine?
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older:A Randomised Contr
Chadox1 Ncov-19 Vaccination Prevents SARS-Cov-2 Pneumonia in Rhesus Macaques 2
M&G Leads $168 Million Vaccitech Financing with $50 Million Capital
Vaccitech Oncology Limited's Chadox1/MVA Prime-Boost
M&G Leads $168 Million Vaccitech Financing with $50 Million Capital Investment
Disease Briefing: Coronaviruses
Heterologous Vaccination Regimens with Self-Amplifying RNA and Adenoviral
European Medicines Agency Recommends Conditional Marketing Authorisation to Chadox1 Coronavirus Vaccine
COVID-19 Response Interim Report
Top View
Insights on SARS-Cov-2: Emerging Outbreaks of Viral Infections and the Need for Heightening the Antiviral Research
Oxford University and Vaccitech Welcome UK Regulatory Emergency Use Authorisation of Coronavirus Vaccine
Can Changing COVID Vaccine Regimens End the Pandemic Faster?
OXFORD 2020: Meeting the Pandemic Challenge CONTENTS
INNOVATION Insights Insights the LATEST INNOVATIONS, COLLABORATIONS and TECHNOLOGY TRANSFER ISSUE 9 MAY 2018 from the UNIVERSITY of OXFORD
A Snapshot of the Global Race for Vaccines Targeting SARS-Cov-2 and the COVID-19 Pandemic
Immunologic Dose-Response to Adenovirus-Vectored
Developmental Therapeutics Immunotherapy
A Life Sciences Ecosystem Like No Other
Edição Ampliada E Atualizada Em 31/12/2020
Arbutus Biopharma and Vaccitech Announce Clinical Trial
A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
Ra Capital's Covid-19 Map
Chadox1 Ncov-19 (AZD1222) Vaccine Candidate Significantly Reduces SARS-Cov-2 Shedding in Ferrets
Development at the Speed of Light: Pharma’S Search for a COVID-19 Vaccine Agenda